December 1976, Managing Director Kazumasa Kobayashi was appointed
President and COO. In conjunction with this, Teruko Kobayashi, who
had succeeded the President, returned to the seat of Chairman and
CEO following the death of Saburo Kobayashi.
Kazumasa Koyabashi, the company's fourth President, is the eldest
son of Saburo and Teruko Kobayashi. After joining the company in
March 1962 and working his way up through such positions as salesman
in the Shinjuku Store and accountant in the Accounting Department,
he studied at Columbia University in the United States. When he
returned to Japan, he worked as the Head of the Planning and Advertising
Sections in October 1966, Director in November 1966, Head of the
Planning Section and Product Sales Department in October 1968, Managing
Director of the Product Division in November 1970, and served as
Head of the Development Section in October 1971 before eventually
being appointed President.
Kobayashi Pharmaceutical, under the direction of the youthful 37-year-old
President, celebrated the 60th anniversary of its founding the following
year in 1977. On October 14, employees and associates bowed their
heads in silent prayer at a commemorative ceremony held at Kanzanji
Spa. In August of that year, Chairman Teruko Kobayashi passed away
at the age of 61.
The President, who rose from his seat to greet the attendees, faced
all the employees who were present and announced that over the past
50 years the company had grown from 714 members to 838 and that
total sales had risen from 10.7 billion to 33 billion yen.
"What Kobayashi Pharmaceutical needs are people, products,
and a sales force. People are the company's foundation, hit products
are the company's development, and hit products cannot be produced
without a sales force. Let us continue to strive for the future
development of the company and the well-being of our employees."
The President's three principles later known as "The Three
H's" (People, Hit Products, and Sales Force; or hito, hitto
shohin, and hanbairyoku in Japanese) were already clear at this
The period of high growth was now over, and a time of stable growth
had begun with the company's feet planted firmly on the ground.
At just such a time, the appearance of the youthful and energetic
manager was welcomed by employees and customers alike.
The new president was welcomed, and a feeling of "Let's get
down to it!" permeated throughout company. Even the President
himself announced a flowing succession of abundant ideas and led
the company unabashedly. The new President went not on the defensive
but rather the offensive, and drove the company to look ahead rather
than behind. Emphasis was placed on business, and a succession of
policies prioritizing development was announced.
At that time, Products Division Director Hiroaki Miyata became
Vice-President of the Manufacturing Division and Head of the Development
Section, and Business Operations Division Director Yutaka Kobayashi
became the Director of the Foreign Operations Division. With these
youthful leaders at the helm, the management at Kobayashi Pharmaceutical
was well on its way to becoming a progressive and highly international
One of these developments was the early shift toward computerization.
Not all sections and departments, however, were doing so well. The
fact is that there were still many problems to be solved and tough
issues remaining in the business environment.